Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RPS6KB1 | P23443 | 2/20 | 0.71 |
| ▸ | ROCK2 | O75116 | 7/20 | 0.60 |
| ▸ | AKT1 | P31749 | 2/20 | 0.60 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12561687 | 0.88 | RPS6KB1 (0.74) | RPS6KB1ROCK2AKT1ROCK1LMNA | |
| SCHEMBL12561730 | 0.88 | RPS6KB1 (0.74) | RPS6KB1ROCK2AKT1ROCK1LMNA | |
| SCHEMBL1984599 | 0.86 | ROCK2 (0.73) | RPS6KB1ROCK2AKT1ROCK1HTT | |
| SCHEMBL1984590 | 0.86 | ROCK2 (0.73) | RPS6KB1ROCK2AKT1ROCK1HTT | |
| SCHEMBL1990390 | 0.86 | ROCK2 (0.69) | RPS6KB1ROCK2AKT1ROCK1GAA | |
| SCHEMBL1991403 | 0.85 | ROCK2 (0.58) | RPS6KB1ROCK2AKT1ROCK1GAA | |
| SCHEMBL1987870 | 0.85 | RPS6KB1 (0.78) | RPS6KB1ROCK2AKT1ROCK1GAA | |
| SCHEMBL1985789 | 0.83 | RPS6KB1 (1.00) | RPS6KB1ROCK2AKT1ROCK1LMNA | |
| SCHEMBL1985785 | 0.83 | RPS6KB1 (1.00) | RPS6KB1ROCK2AKT1ROCK1LMNA | |
| SCHEMBL1989572 | 0.83 | RPS6KB1 (0.72) | RPS6KB1ROCK2AKT1ROCK1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110150833-A1 | BENZOPYRANS AND ANALOGS AS RHO KINASE INHIBITORS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2011-06-23 | — | — | US | disclosed |
| US-20110150833-A1 | BENZOPYRANS AND ANALOGS AS RHO KINASE INHIBITORS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2011-06-23 | — | — | US | disclosed |
| WO-2009079008-A1 | BENZOPYRANS AND ANALOGS AS RHO KINASE INHIBITORS | FENG YANGBO (US) | 2009-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110150833-A1 | BENZOPYRANS AND ANALOGS AS RHO KINASE INHIBITORS | ROCK1, RHOA, RHOT2 | RPS6KB1 42/4885ROCK2 4/4885AKT1 31/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.